| James Viapiano, MD | |
|
14 Richland Medical Park Dr Ste 200, Columbia, SC 29203-6882 | |
| (803) 296-7846 | |
| (803) 296-9699 |
| Full Name | James Viapiano |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 14 Richland Medical Park Dr Ste 200, Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104860675 | NPI | - | NPPES |
| 341829 | Medicaid | SC | |
| EO1362541 | Medicaid | NY | |
| OVN0284 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 34182 (South Carolina) | Primary |
| 207L00000X | Anesthesiology | 042-0010256 (Vermont) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health Medical Group-midlands | 5991099707 | 865 |
News Archive
In a post in the Center for Strategic & International Studies' "Smart Global Health" blog, Julia Nagel, web and social media assistant at the Global Health Policy Center, examines "the obstacles that global malaria control efforts face," writing that "eradicating malaria is complex and difficult" because "there are four species of human malaria" that "respond differently to medicines, exhibit drug resistance in different ways, and most importantly, make finding a fool-proof vaccine against all malaria nearly impossible."
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Of Rock Hill Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811977200 PECOS PAC ID: 6305740259 Enrollment ID: O20031121000543 |
News Archive
In a post in the Center for Strategic & International Studies' "Smart Global Health" blog, Julia Nagel, web and social media assistant at the Global Health Policy Center, examines "the obstacles that global malaria control efforts face," writing that "eradicating malaria is complex and difficult" because "there are four species of human malaria" that "respond differently to medicines, exhibit drug resistance in different ways, and most importantly, make finding a fool-proof vaccine against all malaria nearly impossible."
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
› Verified 4 days ago
| Entity Name | Prisma Health Medical Group-midlands |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275988321 PECOS PAC ID: 5991099707 Enrollment ID: O20160802001226 |
News Archive
In a post in the Center for Strategic & International Studies' "Smart Global Health" blog, Julia Nagel, web and social media assistant at the Global Health Policy Center, examines "the obstacles that global malaria control efforts face," writing that "eradicating malaria is complex and difficult" because "there are four species of human malaria" that "respond differently to medicines, exhibit drug resistance in different ways, and most importantly, make finding a fool-proof vaccine against all malaria nearly impossible."
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Viapiano, MD Po Box 22265, Belfast, ME 04915-4473 Ph: (803) 296-7320 | James Viapiano, MD 14 Richland Medical Park Dr Ste 200, Columbia, SC 29203-6882 Ph: (803) 296-7846 |
News Archive
In a post in the Center for Strategic & International Studies' "Smart Global Health" blog, Julia Nagel, web and social media assistant at the Global Health Policy Center, examines "the obstacles that global malaria control efforts face," writing that "eradicating malaria is complex and difficult" because "there are four species of human malaria" that "respond differently to medicines, exhibit drug resistance in different ways, and most importantly, make finding a fool-proof vaccine against all malaria nearly impossible."
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer whose disease progressed on or after prior endocrine therapy.
Pharmaceutical companies are focusing on more unique approaches in the development of educational and experiential solutions for their health care customers at medical conferences, according to Joe Scrocco, chief executive officer of OneWorld, Inc., a leading pharmaceutical consulting firm.
The rate of chronic health conditions among children in the U.S. increased from 12.8 percent in 1994 to 26.6 percent in 2006, for conditions such as obesity, asthma and behavior/learning problems, according to a study in the February 17 issue of JAMA.
New research published in The Lancet Diabetes & Endocrinology suggests that, when considering overall costs of healthcare, obese patients with type 2 diabetes, especially those with recent disease onset, should be prioritised for obesity surgery over those without type 2 diabetes, since many patients see a reversal of diabetes after surgery and thus need fewer expensive diabetes medications or treatment for complications in future.
› Verified 4 days ago
William D. Hyman, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 5 Richland Medical Park, Columbia, SC 29203 Phone: 803-434-2797 Fax: 803-434-7038 | |
Dr. Kamran Zargham Koranloo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1821 Clemson Rd, Columbia, SC 29229 Phone: 803-788-5916 | |
Dr. Margaret Victoria Ridgeway Pollard, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5 Richland Medical Park Dr, Columbia, SC 29203 Phone: 803-434-6151 | |
Dr. William B Parks Iii, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1330 Taylor St, Columbia, SC 29201 Phone: 803-296-5134 Fax: 803-296-5499 | |
Jerome M. Davis, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1655 Bernardin Ave, Suite 350, Columbia, SC 29204 Phone: 803-865-4780 Fax: 803-865-4932 | |
Patrick L. Laporte, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5 Richland Medical Park Dr, Columbia, SC 29203 Phone: 803-434-6151 Fax: 803-296-5137 | |
Jenna Zauk, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5 Richland Medical Park Dr, Columbia, SC 29203 Phone: 803-434-6151 Fax: 803-296-5137 |